Environmental

ARQT’s R&D intensity supports a science-driven footprint, but the absence of disclosed emissions, energy, and waste metrics leaves its environmental positioning less transparent than better-reporting peers.

The company’s asset-light biopharma model likely limits direct operational emissions versus manufacturing-heavy peers, yet this advantage is not evidenced by comprehensive sustainability disclosure.

No material environmental controversies are provided, but limited disclosure on climate and resource management constrains relative confidence versus peers with fuller reporting.

Because environmental risk is mainly indirect through laboratory and supply-chain practices, ARQT appears broadly average rather than structurally advantaged versus peers.

Social

High R&D spending indicates continued investment in patient-focused innovation, which supports social relevance, but peer comparison is limited by the lack of clinical-trial and access metrics.

Stock-based compensation at 9.4% of revenue suggests meaningful employee alignment, though it also implies dilution pressure that peers with tighter compensation discipline may avoid.

No workforce, safety, or product-quality controversies are disclosed here, but the absence of broader social metrics weakens evidence of superior peer positioning.

ARQT’s social profile appears moderately constructive for a development-stage biotech, yet it remains less demonstrably strong than peers with clearer disclosure on patients and employees.

Governance

Debt-to-equity of 0.52 and net debt to EBITDA of 1.84 indicate manageable leverage, which supports governance discipline relative to more highly levered peers.

Stock-based compensation near 9.4% of revenue is material, and peers with lower equity dilution generally show stronger capital-allocation governance.

The provided metrics do not indicate severe governance failures, but limited disclosure on board oversight, independence, and shareholder protections prevents a stronger relative score.

Overall governance looks adequate rather than leading, because capital structure discipline is acceptable while compensation and disclosure transparency remain only average versus peers.

Overall Score

ARQT’s ESG positioning is broadly average versus peers, with manageable governance and a science-driven social profile offset by limited environmental and disclosure transparency.

Score Driver: Limited ESG Disclosure Relative To Peers